Sign In
Buy ENTA
Enanta Pharmaceuticals Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be positive at 88.69. In total, the insiders bought 1.39M and sold 42.79K ENTA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
88.69 |
| ● Buy | 1.39M shares |
| ● Sell | 42.79K shares |
|
77% Buy Activity
Negligible or No Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Mar 11, 2026 Buy |
Carter Bruce L A Director |
20 000 Value: $283.4K |
||
|
Mar 11, 2026 Buy |
Foletta Mark G Director |
20 000 Value: $283.4K |
||
|
Mar 11, 2026 Buy |
Hata Yujiro S Director |
20 000 Value: $283.4K |
||
|
Mar 11, 2026 Buy |
Peterson Kristine Director |
20 000 Value: $283.4K |
||
|
Mar 11, 2026 Buy |
Vance Terry Director |
20 000 Value: $283.4K |
||
|
Mar 11, 2026 Buy |
Russell Lesley Director |
20 000 Value: $283.4K |
||
|
Feb 12, 2026 Sell |
Luly Jay R. President And CEO |
6 155 Value: $87.7K |
||
|
Feb 12, 2026 Buy |
Or Yat Sun Chief Scientific Officer |
1 650 Value: $22.8K |
||
|
Feb 12, 2026 Buy |
Or Yat Sun Chief Scientific Officer |
5 225 Value: $72.3K |
||
|
Feb 12, 2026 Buy |
Rottinghaus Scott T. Chief Medical Officer |
5 225 Value: $72.3K |
||
|
Feb 12, 2026 Sell |
Kieffer Tara Lynn Chief Product Strategy Officer |
3 257 Value: $46.4K |
||
|
Feb 12, 2026 Buy |
Luu Brendan Chief Business Officer |
1 575 Value: $21.8K |
||
|
Feb 12, 2026 Buy |
Luu Brendan Chief Business Officer |
4 987 Value: $69.0K |
||
|
Feb 12, 2026 Buy |
Kowalsky Matthew Paul Chief Legal Officer |
4 175 Value: $57.8K |
||
|
Feb 12, 2026 Sell |
Kowalsky Matthew Paul Chief Legal Officer |
1 902 Value: $27.1K |
||
|
Feb 12, 2026 Buy |
Kowalsky Matthew Paul Chief Legal Officer |
1 318 Value: $18.2K |
||
|
Feb 12, 2026 Sell |
Luu Brendan Chief Business Officer |
3 257 Value: $46.4K |
||
|
Feb 12, 2026 Buy |
Kieffer Tara Lynn Chief Product Strategy Officer |
4 987 Value: $69.0K |
||
|
Feb 12, 2026 Buy |
Kieffer Tara Lynn Chief Product Strategy Officer |
1 575 Value: $21.8K |
||
|
Feb 12, 2026 Sell |
Rottinghaus Scott T. Chief Medical Officer |
3 413 Value: $48.6K |
||
|
Feb 12, 2026 Buy |
Rottinghaus Scott T. Chief Medical Officer |
1 650 Value: $22.8K |
||
|
Feb 12, 2026 Sell |
Or Yat Sun Chief Scientific Officer |
3 413 Value: $48.6K |
||
|
Feb 12, 2026 Buy |
Luly Jay R. President And CEO |
15 200 Value: $210.4K |
||
|
Feb 12, 2026 Buy |
Luly Jay R. President And CEO |
4 800 Value: $66.4K |
||
|
Dec 05, 2025 Sell |
Luly Jay R. President And CEO |
4 743 Value: $67.5K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
